Hatano, Taku
278  results:
?
1

Safinamide as adjunctive therapy to levodopa monotherapy fo..:

Nishikawa, Noriko ; Hatano, Taku ; Nishioka, Kenya...
Journal of the Neurological Sciences.  461 (2024)  - p. 123051 , 2024
 
?
4

Novel characteristics of the temporal transition to maximum..:

Hayasaka, Sachi ; Hatori, Kozo ; Nojiri, Shuko...
Clinical Parkinsonism & Related Disorders.  10 (2024)  - p. 100244 , 2024
 
?
5

Extracellular vesicles contain filamentous alpha-synuclein ..:

Ishiguro, Yuta ; Tsunemi, Taiji ; Shimada, Tomoyo...
Biochemical and Biophysical Research Communications.  703 (2024)  - p. 149620 , 2024
 
?
6

Efficacy and Safety of Elobixibat in Parkinson's Disease wi..:

Hatano, Taku ; Oyama, Genko ; Shimo, Yasushi...
Movement Disorders Clinical Practice.  11 (2024)  4 - p. 352-362 , 2024
 
?
 
?
 
?
 
?
13

Response to letter to editor 'comment on: Safinamide as adj..:

Nishikawa, Noriko ; Ishida, Takayuki ; Hatano, Taku.
Journal of the Neurological Sciences.  462 (2024)  - p. 123101 , 2024
 
?
14

The Role of Immune Dysfunction in Parkinson's Disease Devel..:

Cossu, Davide ; Hatano, Taku ; Hattori, Nobutaka
International Journal of Molecular Sciences.  24 (2023)  23 - p. 16766 , 2023
 
1-15